SLC7A11 and cancer: We extended these findings by using the a physiologically relevant concentration of KYN (45 μM of KYN, Figure S5B,C, Table S1) and four additional cancer cell lines, SKOV3, HT1080, PT45 and U2OS that showed varying baseline expression of SLC7A11 (Figure S5D-N).